Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margo A Denke

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|August 30, 2005
Diet, lifestyle, and nonstatin trials: review of time to benefitMargo A Denke
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Combination therapyMargo A Denke
Current Atherosclerosis Reports|October 19, 2006
Dietary fats, fatty acids, and their effects on lipoproteinsMargo A Denke
Current Atherosclerosis Reports|October 4, 2002
Metabolic syndromeMargo A Denke
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A novel therapeutic approachMargo A Denke
The Journal of the American Osteopathic Association|October 7, 2004
Coadministration of multidrug therapy to achieve lipid goalsMargo A Denke
The Journal of the American Osteopathic Association|October 7, 2004
Utility of currently available modes of therapy in reaching lipid goalsKelly Anne Spratt, Margo A Denke
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 27, 2007
Comparison of testosterone, alendronate, and a combination of both therapies in men with low bone mineral densityBrian J Welch, Margo A Denke, Asra Kermani, et al.
Mayo Clinic Proceedings|May 13, 2005
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trialThomas A Pearson, Margo A Denke, Patrick E McBride, et al.
Medical Care|April 28, 2006
The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patientsKathleen A Foley, Margo A Denke, Sachin Kamal-Bahl, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|August 30, 2005
Diet, lifestyle, and nonstatin trials: review of time to benefitMargo A Denke
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Combination therapyMargo A Denke
Current Atherosclerosis Reports|October 19, 2006
Dietary fats, fatty acids, and their effects on lipoproteinsMargo A Denke
Current Atherosclerosis Reports|October 4, 2002
Metabolic syndromeMargo A Denke
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A novel therapeutic approachMargo A Denke
The Journal of the American Osteopathic Association|October 7, 2004
Coadministration of multidrug therapy to achieve lipid goalsMargo A Denke
The Journal of the American Osteopathic Association|October 7, 2004
Utility of currently available modes of therapy in reaching lipid goalsKelly Anne Spratt, Margo A Denke
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 27, 2007
Comparison of testosterone, alendronate, and a combination of both therapies in men with low bone mineral densityBrian J Welch, Margo A Denke, Asra Kermani, et al.
Mayo Clinic Proceedings|May 13, 2005
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trialThomas A Pearson, Margo A Denke, Patrick E McBride, et al.
Medical Care|April 28, 2006
The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patientsKathleen A Foley, Margo A Denke, Sachin Kamal-Bahl, et al.
Pageof 2